<DOC>
	<DOCNO>NCT02733887</DOCNO>
	<brief_summary>The lymph nod mass , positron emission tomography/computed tomography ( PET/CT ) standardize uptake value ( SUV ) result , whole body magnetic resonance imaging ( MRI ) intravoxel incoherent motion ( IVIM ) sequence D , D* , f value MRI volume lymphoma patient compare chemotherapy project prospectively provide data evaluate dependency difference PET/CT whole body MRI lymphoma stag therapeutic evaluation . Long-term therapeutic effect index obtain follow-up visit patient Overall Survival ( OS ) , Progression Free Survival ( PFS ) etc . use evaluate diagnostic sensitivity difference MRI PET/CT . The research could provide new method nonionizing radiation iconography physician give appropriate treatment predict prognosis .</brief_summary>
	<brief_title>MRI Compared PET/CT Staging Treatment Response Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>Lymphoma subtypes diagnose basis tissue sample obtain biopsy surgery accord criterion outline current World Health Organization ( WHO ) classification hematologic lymphoid malignancy , reference pathologist . Patients give write informed consent refer DWIMRI 18FFDGPET/CT . Stable physical medical condition ( patient conscious comfortable , schedule elective diagnostic imaging ) . Pregnancy , general contraindication MRI , therapeutic intervention DWIMRI 18FFDGPET/CT use .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>